Literature DB >> 24259240

Insulin resistance and lipid profiles in HIV-infected Thai children receiving lopinavir/ritonavir-based highly active antiretroviral therapy.

Prapai Dejkhamron, Kevalee Unachak, Linda Aurpibul, Virat Sirisanthana.   

Abstract

BACKGROUND: Lopinavir/ritonavir (LPV/r) is associated with insulin resistance (IR). We aim to determine the prevalence of IR, dyslipidemia and their inter-relationships with adipokines in HIV-infected children treated with LPV/r-based highly active antiretroviral therapy (HAART).
METHODS: Twenty-eight children were enrolled. Fasting glucose, insulin, lipid profiles, adipokines, and oral glucose tolerance tests were performed.
RESULTS: The prevalence of IR, pre-diabetes mellitus, and hypertriglyceridemia was 42.9(12/28), 10.7(3/28), and 75.0(21/28)% respectively. No case met the definition for diabetes mellitus (DM) and lipodystrophy. Children with IR had higher BMI z-score, triglyceride levels but unchanged leptin or adiponectin levels compared to those without IR. Longer duration of LPV/r-based HAART was associated with increased levels of triglyceride and total cholesterol.
CONCLUSIONS: We describe high prevalence of IR, pre-diabetes mellitus, and dyslipidemia among HIV-infected children receiving LPV/r-based HAART. Pre-diabetes mellitus or DM or IR screening might be important for early diagnosis and intervention in these children.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24259240     DOI: 10.1515/jpem-2013-0253

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  8 in total

Review 1.  Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Authors:  Todd Hulgan
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

2.  Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents.

Authors:  Mitchell E Geffner; Kunjal Patel; Denise L Jacobson; Julia Wu; Tracie L Miller; Rohan Hazra; Mariana Gerschenson; Tanvi Sharma; Margarita Silio; Jennifer Jao; Jody K Takemoto; Russell B Van Dyke; Linda A DiMeglio
Journal:  AIDS       Date:  2018-03-13       Impact factor: 4.177

3.  Metabolic effects of initiating lopinavir/ritonavir-based regimens among young children.

Authors:  Kunjal Patel; Jane Lindsey; Konstantia Angelidou; Grace Aldrovandi; Paul Palumbo
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

Review 4.  Universal antiretroviral therapy for HIV-infected children: a review of the benefits and risks to consider during implementation.

Authors:  Linda Barlow-Mosha; Victor Musiime; Mary-Ann Davies; Andrew J Prendergast; Philippa Musoke; George Siberry; Martina Penazzato
Journal:  J Int AIDS Soc       Date:  2017-06-27       Impact factor: 5.396

5.  Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception.

Authors:  Nadia Kancheva Landolt; Torsak Bunupuradah; Jullapong Achalapong; Pope Kosalaraksa; Witaya Petdachai; Chaiwat Ngampiyaskul; Sasiwimol Ubolyam; Narukjaporn Thammajaruk; Stephen Kerr; Jintanat Ananworanich
Journal:  J Virus Erad       Date:  2017-01-01

6.  The Lipodystrophy Syndrome in HIV-Infected Children under Antiretroviral Therapy: A First Report from the Central Africa.

Authors:  Honoré Kalombayi Tshamala; Loukia Aketi; Pierre Manianga Tshibassu; Mathilde Bothale Ekila; Eric Musalu Mafuta; Patrick Kalambayi Kayembe; Michel Ntetani Aloni; Joseph Diayisu Shiku
Journal:  Int J Pediatr       Date:  2019-03-03

7.  Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional Study.

Authors:  Michela Sonego; Maria José Sagrado; Gustavo Escobar; Marzia Lazzerini; Estefanie Rivas; Rocio Martín-Cañavate; Elsy Pérez de López; Sandra Ayala; Luis Castaneda; Pilar Aparicio; Estefanía Custodio
Journal:  Pediatr Infect Dis J       Date:  2016-10       Impact factor: 2.129

8.  Correlates of fasting blood glucose among children living with hiv in a Nigerian tertiary hospital: a cross-sectional study.

Authors:  Ijeoma Onyinye Ohuche; Ugo Nnenna Chikani; Elizabeth Eberechi Oyenusi; Justus Uchenna Onu; Abiola Oduwole
Journal:  BMC Pediatr       Date:  2020-10-02       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.